ATE489462T1 - Antimikrobielles polypeptid und nutzung davon - Google Patents

Antimikrobielles polypeptid und nutzung davon

Info

Publication number
ATE489462T1
ATE489462T1 AT03725651T AT03725651T ATE489462T1 AT E489462 T1 ATE489462 T1 AT E489462T1 AT 03725651 T AT03725651 T AT 03725651T AT 03725651 T AT03725651 T AT 03725651T AT E489462 T1 ATE489462 T1 AT E489462T1
Authority
AT
Austria
Prior art keywords
nlss
polypeptide
amino acid
units
acid residues
Prior art date
Application number
AT03725651T
Other languages
English (en)
Inventor
Tetsuhiko Yoshida
Masayoshi Kume
Yoshinao Yamada
Yoko Matsuda
Hiroki Kourai
Original Assignee
Toagosei Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toagosei Co Ltd filed Critical Toagosei Co Ltd
Application granted granted Critical
Publication of ATE489462T1 publication Critical patent/ATE489462T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT03725651T 2002-04-25 2003-04-24 Antimikrobielles polypeptid und nutzung davon ATE489462T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002124830 2002-04-25
PCT/JP2003/005225 WO2003091429A1 (en) 2002-04-25 2003-04-24 Antimicrobial polypeptide and utizliation thereof

Publications (1)

Publication Number Publication Date
ATE489462T1 true ATE489462T1 (de) 2010-12-15

Family

ID=29267540

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03725651T ATE489462T1 (de) 2002-04-25 2003-04-24 Antimikrobielles polypeptid und nutzung davon

Country Status (8)

Country Link
US (1) US7482328B2 (de)
EP (1) EP1502949B1 (de)
JP (1) JP4423542B2 (de)
CN (1) CN1650005B (de)
AT (1) ATE489462T1 (de)
AU (1) AU2003231471A1 (de)
DE (1) DE60335101D1 (de)
WO (1) WO2003091429A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4507080B2 (ja) 2004-07-30 2010-07-21 東亞合成株式会社 抗菌ペプチド及びその利用
MX2007002057A (es) * 2004-08-18 2007-07-19 Novabiotics Ltd Peptidos antimicrobianos que comprenden un motivo que contiene arginina y/o lisina.
AU2011235933B2 (en) * 2004-08-18 2012-06-07 Novabiotics Limited Antimicrobial peptides comprising an arginine- and/or lysine-containing motif
JP4507084B2 (ja) * 2004-10-26 2010-07-21 東亞合成株式会社 アポトーシス誘導性ペプチド及びその利用
JP4730584B2 (ja) 2004-12-06 2011-07-20 東亞合成株式会社 抗菌ペプチド及びその利用
WO2006088010A1 (ja) 2005-02-15 2006-08-24 Toagosei Co., Ltd. 抗菌ペプチド及びその利用
GB0517090D0 (en) * 2005-08-19 2005-09-28 Tcp Innovations Ltd ApoE mimetic agents
JP4831410B2 (ja) * 2006-02-28 2011-12-07 東亞合成株式会社 抗ウイルス性ペプチドおよび抗ウイルス剤
JP4788958B2 (ja) * 2006-02-28 2011-10-05 東亞合成株式会社 抗ウイルス性ペプチドおよびその利用
WO2008032783A1 (en) * 2006-09-14 2008-03-20 Toagosei Co., Ltd. Artificial antibacterial peptide and use thereof
JP5218843B2 (ja) * 2006-09-14 2013-06-26 東亞合成株式会社 抗菌ペプチド及びその利用
GB0702021D0 (en) * 2007-02-02 2007-03-14 Novabiotics Ltd Peptides and their use
RU2011101391A (ru) * 2008-06-16 2012-08-10 Хираликс Б.В. (Nl) Ингибиторы пептидиларгининдезиминазы (pad)
CN102321155A (zh) * 2008-12-19 2012-01-18 华中科技大学 Tnf结合肽和tnfr1封闭肽及其在治疗溃疡性结肠炎中的应用
US9238796B2 (en) 2010-06-04 2016-01-19 Toagosei Co. Ltd. Cell growth-promoting peptide and use thereof
US9303063B2 (en) 2011-03-18 2016-04-05 Duke University Peptide compounds for suppressing inflammation
EP2685999A4 (de) 2011-03-18 2015-07-15 Univ Duke Peptide zur unterdrückung von entzündungen
WO2013180011A1 (ja) 2012-05-28 2013-12-05 東亞合成株式会社 抗菌ペプチド及びその利用
JP6311935B2 (ja) 2012-10-18 2018-04-18 東亞合成株式会社 ２型ｔｎｆ受容体の発現を抑制する合成ペプチド及びその利用
CN104961801B (zh) * 2015-07-13 2018-01-19 兰州大学 一种具有多靶点的抗菌多肽偶联物及其二聚物的合成和应用
JP2018529689A (ja) * 2015-09-17 2018-10-11 ソウル大学校産学協力団Ｓｅｏｕｌ Ｎａｔｉｏｎａｌ Ｕｎｉｖｅｒｓｉｔｙ Ｒ＆Ｄｂ Ｆｏｕｎｄａｔｉｏｎ グラム陰性菌に対する抗菌活性を示す切断または折り畳まれたヘリックスペプチドまたはペプチド類似体およびその用途
CN108400003A (zh) * 2016-03-20 2018-08-14 李忠波 一种防菌抗腐蚀的变压器
CN108806871A (zh) * 2016-03-20 2018-11-13 李忠波 一种输电用防霉防菌抗腐蚀电缆
CN108084269A (zh) * 2017-12-28 2018-05-29 桂林医学院 一种多肽自组装纳米载体及其制备方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0510912B1 (de) * 1991-04-24 1998-01-07 Morinaga Milk Industry Co., Ltd. Antimikrobielles Peptid und antimikrobieller Wirkstoff
US5547939A (en) * 1991-06-14 1996-08-20 The Regents Of The University Of California Broad spectrum antimicrobial compounds and methods of use
US6063612A (en) * 1991-12-13 2000-05-16 Sri International Antiviral reagents based on RNA-binding proteins
AU687010B2 (en) 1992-07-17 1998-02-19 Dana-Farber Cancer Institute Method of intracellular binding of target molecules
US5789542A (en) * 1994-04-22 1998-08-04 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Amphipathic peptides
US5807746A (en) * 1994-06-13 1998-09-15 Vanderbilt University Method for importing biologically active molecules into cells
US5834184A (en) 1995-05-17 1998-11-10 Harada; Kazuo In vivo selection of RNA-binding peptides
AU6940796A (en) * 1995-08-23 1997-03-19 University Of British Columbia, The Antimicrobial cationic peptides and methods of screening for the same
JP3037605B2 (ja) * 1995-12-27 2000-04-24 ティーポール株式会社 殺菌洗浄剤組成物
ES2198547T3 (es) * 1996-02-02 2004-02-01 Asahikasei Aime Co., Ltd. Solucion para la conservacion y esterilizacion de lentes de contacto.
US6180604B1 (en) * 1996-08-21 2001-01-30 Micrologix Biotech Inc. Compositions and methods for treating infections using analogues of indolicidin
US5962415A (en) * 1996-09-20 1999-10-05 Bristol-Myers Squibb Co. Compositions comprising a peptide inhibitor of nuclear protein translocation and an immunosuppressant and methods of use thereof
US5877282A (en) * 1996-09-20 1999-03-02 Bristol-Myers Squibb Company Peptide inhibitors of nuclear protein translocation having nuclear localization sequences and methods of use thereof
US6143498A (en) 1997-05-14 2000-11-07 Human Genome Sciences, Inc. Antimicrobial peptide
AUPP051497A0 (en) 1997-11-24 1997-12-18 University Of Melbourne, The Antimicrobial peptides
WO1999029721A1 (en) * 1997-12-10 1999-06-17 Washington University Anti-pathogen system and methods of use thereof
US6303575B1 (en) * 1998-05-12 2001-10-16 The Regents Of The University Of California Indolicidin analogs and methods of using same
CA2328457A1 (en) * 1998-06-20 1999-12-29 Washington University Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
US6476189B1 (en) * 1998-08-12 2002-11-05 National Institute Of Agrobiological Sciences Antibacterial peptides and antibacterial agents containing such peptides as an effective ingredient
JP2002522556A (ja) 1998-08-14 2002-07-23 バイオネブラスカ，インコーポレイテッド アメリカカエルの皮膚から単離された抗菌性ペプチド
GB9918156D0 (en) 1999-08-02 1999-10-06 Zeneca Ltd Synthetic peptides
CA2392490A1 (en) * 1999-11-24 2001-05-31 Mcs Micro Carrier Systems Gmbh Polypeptides comprising multimers of nuclear localization signals or of protein transduction domains and their use for transferring molecules into cells
JP2001186887A (ja) 2000-01-06 2001-07-10 Suntory Ltd サソリ毒由来の抗菌ペプチド
JP2002020320A (ja) * 2000-06-30 2002-01-23 Santen Pharmaceut Co Ltd 点眼液用防腐剤
US6841535B2 (en) * 2000-07-31 2005-01-11 Active Motif Peptide-mediated transfection agents and methods of use

Also Published As

Publication number Publication date
EP1502949B1 (de) 2010-11-24
JP4423542B2 (ja) 2010-03-03
EP1502949A4 (de) 2006-03-15
DE60335101D1 (de) 2011-01-05
US20060057668A1 (en) 2006-03-16
JPWO2003091429A1 (ja) 2005-09-02
US7482328B2 (en) 2009-01-27
EP1502949A1 (de) 2005-02-02
AU2003231471A1 (en) 2003-11-10
CN1650005B (zh) 2010-12-08
WO2003091429A1 (en) 2003-11-06
CN1650005A (zh) 2005-08-03

Similar Documents

Publication Publication Date Title
DE60335101D1 (de) Antimikrobielles polypeptid und nutzung davon
EP2266590A3 (de) Wirkstoff-Abgabesystem und Verfahren zum Schutz und zur Verabreichung von Wirkstoffen
DK1025124T3 (da) Human interferon-alfa-analoge med lav toksicitet
HUP0300684A2 (hu) Szomatosztatin analógok, azokat tartalmazó gyógyszerkészítmények és alkalmazásuk
BR0305074A (pt) Composições cosméticas com alta afinidade
ATE368053T1 (de) Antimikrobielle peptide
DE602005023315D1 (de) Antimikrobielle peptide mit einem arginin- und /oder lysin-haltigen motiv
ATE509618T1 (de) Nanoteilchenförmige zusammensetzungen mit einem peptid als oberflächenstabilisator
DE68916932D1 (de) Antimikrobielle peptide, zusammensetzungen, die diese enthalten, und verwendungen daraus.
DE60327786D1 (de) Kdr-peptide und diese enthaltende impfstoffe
BRPI0811320A2 (pt) Surfactantes reconstituídos com propriedades melhoradas
DE69532996D1 (de) Peptidanaloge des menschlichen basischen myelinproteins
DE69731373D1 (de) Cc-chemokinzeptor c-c ckr-5, dessen derivate und verwendungen
EP0975351A4 (de) Behandlung der multiplen sklerose durch einnahme oder inhalation von copolymer-1
BR0211187A (pt) Composição que contém um peptìdeo e um pigmento e o uso da mesma no escurecimento da pele
BG104267A (en) Aminoterminally incised rantes as haemokin antagonists
WO2006113681A3 (en) Plant-derived elastin binding protein ligands and methods of using the same
WO2001005810A3 (de) CYCLISCHE PEPTIDDERIVATE ALS INHIBITOREN DES INTEGRINS αvβ¿6?
NO940299L (no) Peptid med organbeskyttende aktivitet
WO1996028470A3 (en) Peptide analogues of human myelin basic protein useful in treating multiple sclerosis
BR0312889A (pt) Polipeptìdeo t20 peguilado
WO2002062304A3 (de) Kosmetische und/oder pharmazeutische mittel acylierte aminosäure und proteinkondensat enthaltend.
NO955067D0 (no) FVII/TF peptider
ATE474589T1 (de) Angiogene peptide und ihre verwendungen
WO2005074626A3 (en) Compositions, methods and uses for a novel family of peptides

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties